Memory Pharmaceuticals Corporation Seeks Unrestricted Release of Montvale, NJ Facility Following License Termination

Summary

The company has submitted a proposal to the regulatory body for the unrestricted release of its facility, following the termination of its byproduct materials license, as outlined in the Environmental Assessment and Finding of No Significant Impact (FONSI) report.